Pharmacokinetics of furegrelate after oral administration to normal humans.

scientific article

Pharmacokinetics of furegrelate after oral administration to normal humans. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1023/A:1015899602741
P698PubMed publication ID2717519

P2093author name stringD B Lakings
J M Friis
J S Mohrland
J T VanderLugt
C M Lunan
P2860cites workThromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxidesQ28619497
Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanesQ42115139
Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylateQ42246687
Thromboxanes: selective biosynthesis and distinct biological propertiesQ67769711
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2Q67799948
Liquid chromatographic-ultraviolet methods for furegrelate in serum and urine: preliminary pharmacokinetic evaluation in the dogQ93607765
P433issue1
P921main subjectpharmacokineticsQ323936
P304page(s)53-57
P577publication date1989-01-01
P1433published inPharmaceutical ResearchQ7180737
P1476titlePharmacokinetics of furegrelate after oral administration to normal humans.
P478volume6

Reverse relations

Q36108052Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal pigletscites workP2860

Search more.